Clinical modalities and therapeutic outcomes; Observational cohort comparison between ever-smokers versus never-smokers of tuberculosis patients in Penang, Malaysia.

Abstract

Keywords

• -

Clinical modalities and therapeutic outcomes; Observational cohort comparison between ever-smokers versus never-smokers of tuberculosis patients in Penang, Malaysia.

Öz

-

Anahtar Kelimeler

• -

References

1. Davies P O, Yew W, Ganguly D, Davidow A L, Reichman L B, Dheda K, Rook G A. Smoking and tuberculosis: the epi- demiological association and immunopathogenesis. Trans R Soc Trop Med Hyg 2006;100:291-8.
2. Hassmiller K. The association between smoking and tu- berculosis. Salud Pşblica de México 2006;(48):201-16.
3. Bates M, Khalakdina A, Pai M, Chang L, Lessa F, Smith K. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med, 2007;167:335-41
4. Lin H, Ezzati M, MurrayM. Tobacco smoke, indoor air pol- lution and tuberculosis: a systematic review and meta- analysis. PLoS Medicine 2007;(4):173-7
5. Bruce N, Perez-Padilla R, Albalak R. Indoor air pollu- tion in developing countries: a major environmental and public health challenge. Bulletin of the World Health Organization 2000;78:1078-92.
6. Wiklinson L. Sir Austin Bradford Hill: medical statistics and the quantitative approach to prevention of disease. Addiction 2000;92:657-66.
7. Reichler M, Reves R, Bur S, et al. Evaluation of investi- gations conducted to detect and prevent transmission of tuberculosis. Am Med Assoc 2002;287(22):2944-49
8. Frieden T, Fujiwara P, Washko R, Hamburg M. Tuberculosis in New York City-turning the tide. N Engl J Med 1995;333:229–33.

9. Pio A, Chaulet P. Tuberculosis handbook. WHO/TB/98.253, Geneva, 1998
10. Burman W, Dalton C, Cohn D, Butler J, Rever R. A cost- effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis. Chest 1997;112:63-70.
11. Ministry of Health Malaysia, Clinical Practice Guidelines On Treatement of tobacco use and dependence. (2002)
12. Centers for disease control and prevention, National Center for Health Statistics. (2008)
13. Leung C, Yew W, Chan C, Tam C, Lam C, Chang K, Chau C, Lau K, Law W. Smoking and tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2003;7:980-6.
14. Abal A, Jayakrishnan B, Parwer S, El Shamy A, Abahussain E, Sharma N, Effect of cigarette smoking on sputum smear conversion in adults with active pulmonary tuberculosis. Respiratory Medicine 2005;99:415-20.
15. Santha T, Garg R, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis, 2002;6:780-8
16. Dye C, Garnett G, Sleeman K, Williams B. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Lancet 1998;352:1886-91.
17. Hopewell P, Pai M, Maher D, Uplekar M, Raviglione M. International standards for tuberculosis care. Lancet Infect Dis 2006;6:710-25.
18. Migliori G, Hopewell P, Blasi F, Spanevello A, Raviglione M. Improving the TB case management: the International Standards for Tuberculosis care. Eur Respir J 2006;28:687-90.
19. Fair E, Hopewell P, Pai M. International Standards for Tuberculosis Care: revisiting the cornerstones of tuber- culosis care and control. Expert Rev Anti Infect Ther 2007;5:61-5.
20. Faustini A, Hall A, Perucci C. Tuberculosis treatment out- comes in Europe: a systematic review. Eur Respir J 2005; (26):503-10.
21. Nelson R. WHO's tuberculosis control strategy said to be insufficient. Lancet Infect Dis 2004;(4):653-8.
22. Mccarthy M. Experts see progress in fight against tubercu- losis. The Lancet 2002;(359):2005-6.
23. Oblast I. Tuberculosis Treatment Interruptions—Ivanovo Oblast, Russian Federation, 1999. World, 50.
24. Chang K., Leung C, Tam C. Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong. Int J Tuberc Lung Dis 2004;(8): 1492-8.
25. Shamaei M, Marjani M, Chitsaz E, et al. First-line anti- tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveil- lance. Int J Tuberc Lung Dis 2009;13(5):236-40.
26. Gajalakshmi V, Peto R, Kanaka T, Jha P. Smoking and mor- tality from tuberculosis and other diseases in India: ret- rospective study of 43 000 adult male deaths and 35 000 controls. The Lancet 2003;(362):507-15.
27. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. BMJ 1976;(2):1525- 36
28. Altel-Gomez M, Alcaide J, Godoy P, Romero M, Hernandez Del I. Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13 038 cases. Int J Tuberc Lung Dis 2005;(9):430-6.
29. Yach D. Partnering for better lung health: improving tobacco and tuberculosis control. Int J Tuberc Lung Dis 2000;(4):693-7.
30. Mauray V, Vijayan V, Shah A. Smoking and tuberculosis: an association overlooked. Int J Tuberc Lung Dis: the official journal of the International Union against Tuberculosis and Lung Disease 2002;(6):942-51.
31. Pai M, Mohan A, Dheda K, et al. Lethal interaction: the colliding epidemics of tobacco and tuberculosis. Expert Rev Anti Infect Ther 2007;(5):385-91.